A role for peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels -: Reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of maloncyl-CoA and reduced expression of malonyl-CoA decarboxlase

被引:208
作者
Campbell, FM
Kozak, R
Wagner, A
Altarejos, JY
Dyck, JRB
Belke, DD
Severson, DL
Kelly, DP
Lopaschuk, GD
机构
[1] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada
[3] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada
[4] Washington Univ, Sch Med, Div Cardiovasc, Cardiovasc Res Ctr, St Louis, MO 63110 USA
关键词
D O I
10.1074/jbc.M106054200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptor alpha (PPAR)alpha is a nuclear receptor transcription factor that has an important role in controlling cardiac metabolic gene expression. We determined whether mice lacking PPARalpha (PPARalpha (-/-) mice) have alterations in cardiac energy metabolism. Rates of palmitate oxidation were significantly decreased in isolated working hearts from PPARalpha (-/-) hearts compared with hearts from age-matched wild type mice (PPARalpha (+/+) mice), (62 +/- 12 versus 154 +/- 65 nmol/g dry weight/min, respectively, p < 0.05). This was compensated for by significant increases in the rates of glucose oxidation and glycolysis. The decreased fatty acid oxidation in PPARalpha (-/-) hearts was associated with increased levels of cardiac malonyl-CoA compared with PPARalpha (+/+) hearts (15.15 +/- 1.63 versus 7.37 +/- 1.31 nmol/g, dry weight, respectively, p < 0.05). Since malonyl-CoA is an important regulator of cardiac fatty acid oxidation, we also determined if the enzymes that control malonyl-CoA levels in the heart are under transcriptional control of PPARalpha. Expression of both mRNA and protein as well as the activity of malonyl-CoA decarboxylase, which degrades malonyl-CoA, were significantly decreased in the PPARalpha (-/-) hearts. In contrast, the expression and activity of acetyl-CoA carboxylase, which synthesizes malonyl-CoA and 5'-AMP-activated protein kinase, which regulates acetyl-CoA carboxylase, were not altered. Glucose transporter expression (GLUT1 and GLUT4) was not different between PPARalpha (-/-) and PPARalpha (+/+) hearts, suggesting that the increase in glycolysis and glucose oxidation in the PPARalpha null mice was not due to direct effects on glucose uptake but rather was occurring secondary to the decrease in fatty acid oxidation. This study demonstrates that PPARalpha is an important regulator of fatty acid oxidation in the heart and that this regulation of fatty acid oxidation may in part occur due to the transcriptional control of malonyl-CoA decarboxylase.
引用
收藏
页码:4098 / 4103
页数:6
相关论文
共 40 条
  • [1] Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα)
    Aoyama, T
    Peters, JM
    Iritani, N
    Nakajima, T
    Furihata, K
    Hashimoto, T
    Gonzalez, FJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) : 5678 - 5684
  • [2] Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter
    Belke, DD
    Larsen, TS
    Gibbs, EM
    Severson, DL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (03): : E420 - E427
  • [3] Glucose and fatty acid metabolism in the isolated working mouse heart
    Belke, DD
    Larsen, TS
    Lopaschuk, GD
    Severson, DL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 277 (04) : R1210 - R1217
  • [4] Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α
    Brandt, JM
    Djouadi, F
    Kelly, DP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 23786 - 23792
  • [5] A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice
    Djouadi, F
    Weinheimer, CJ
    Saffitz, JE
    Pitchford, C
    Bastin, J
    Gonzalez, FJ
    Kelly, DP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (06) : 1083 - 1091
  • [6] Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism
    Dyck, JRB
    Berthiaume, LG
    Thomas, PD
    Kantor, PF
    Barr, AJ
    Barr, R
    Singh, D
    Hopkins, TA
    Voilley, N
    Prentki, M
    Lopaschuk, GD
    [J]. BIOCHEMICAL JOURNAL, 2000, 350 : 599 - 608
  • [7] Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation
    Dyck, JRB
    Barr, AJ
    Barr, RL
    Kolattukudy, PE
    Lopaschuk, GD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (06): : H2122 - H2129
  • [8] Peroxisome proliferator-activated receptors: insight into multiple cellular functions
    Escher, P
    Wahli, W
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 448 (02) : 121 - 138
  • [9] Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
    Forman, BM
    Chen, J
    Evans, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4312 - 4317
  • [10] Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene
    Frohnert, BI
    Hui, TY
    Bernlohr, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) : 3970 - 3977